Institutional Ownership
Intensity Therapeutics Inc
CUSIP 45828J202COM NEWQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
10
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 26.0K | $153.0K |
| 2 | Sapient Capital LLC | 26.0K | $152.9K |
| 3 | Nano Cap New Millennium Growth Fund L P | 25.0K | $147.0K |
| 4 | Rothschild Wealth LLC | 23.3K | $137.0K |
| 5 | Mesirow Financial Investment Management, Inc. | 14.1K | $83.0K |
| 6 | Wells Fargo & Company/Mn | 200 | $1.2K |
| 7 | Osaic Holdings, Inc. | 200 | $1.2K |
| 8 | Ubs Group AG | 192 | $1.1K |
| 9 | Tower Research Capital LLC (Trc) | 67 | $394 |
| 10 | Morgan Stanley | 20 | $118 |